Difference between revisions of "Lung Density Biomarker Ctte"

From QIBA Wiki
Jump to navigation Jump to search
 
(218 intermediate revisions by 7 users not shown)
Line 1: Line 1:
 
__NOTOC__
 
__NOTOC__
−
This Wiki is for collaborative creation of QIBA's Chronic Obstructive Pulmonary Disease (COPD) and Asthma Committee materials and ongoing activities.
+
:Co-chairs: Charles Hatt, PhD; Miranda Kirby, PhD
 +
:RSNA Staff Support: Julie Lisiecki
 +
* [http://tinyurl.com/QIBA-CT-Lung-Density-Roster Roster]
  
 +
== Scope ==
  
−
'''Mission''': Reduce and characterize bias and variance across manufacturers, versions, and sites in support of quantitative CT lung densitometry and morphology.   
+
'''Scope''': Quantitative CT lung densitometry and morphology for COPD and related diseases.   
  
 
'''Initial Objectives''':
 
'''Initial Objectives''':
Line 11: Line 14:
 
:: This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.
 
:: This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.
  
 +
==Recent Meetings/Call Summaries==
  
 +
*[[Media:09 27 2023 QIBA CT Lung Density BC Call Summary-FINAL.pdf | September 27, 2023]]
 +
*[[Media:08 23 2023 QIBA CT Lung Density BC Call Summary-FINAL.pdf | August 23, 2023]]
 +
*[[Media:07 26 2023 QIBA CT Lung Density BC Call Summary-FINAL.pdf | July 26, 2023]]
 +
*[[Media:05 24 2023 QIBA CT Lung Density BC Call Summary-FINAL.pdf | May 24, 2023]]
 +
*[[Media:04 26 2023 QIBA CT Lung Density BC Call Summary-FINAL.pdf | April 26, 2023]]
 +
*[[Media:02 22 2023 QIBA CT Lung Density BC Call Summary-FINAL.pdf | February 22, 2023]]
 +
*[[Media:10 26 2022 QIBA CT Lung Density BC Call Summary-FINAL.pdf | October 26, 2022]]
 +
*[[Media:09 21 2022 QIBA CT Lung Density BC Call Summary-FINAL.pdf | September 21, 2022]]
 +
*[[Media:07 27 2022 QIBA CT Lung Density BC Call Summary-FINAL.pdf | July 27, 2022]]
 +
*[[Media:05 25 2022 QIBA CT Lung Density BC Call Summary-FINAL.pdf | May 25, 2022]]
 +
*[[Media:04 27 2022 QIBA CT Lung Density BC Call Summary-FINAL.pdf | April 27, 2022]]
 +
*[[Media:03 23 2022 QIBA CT Lung Density BC Call Summary-FINAL.pdf | March 23, 2022]]
 +
*[[Media:01 26 2022 QIBA CT Lung Density BC Call Summary-FINAL.pdf | January 26, 2022]]
 +
 
  
−
==Project Snapshot==
+
'''''[[Lung Density/COPD BC Call Summaries Archive]]'''''
  
 +
==Profile Development==
 +
Status - <summarize current status>
  
−
===Profiling Activities===
+
A Google link for Public Comment Resolution has been created for ease of sharing updates with the group:
−
Write Profile documents to which equipment and sites can conform to accomplish Quantification goals.
+
https://docs.google.com/document/d/1uOzBaB_77vLSv8FKtQ59AxpfcAswtJ4t/edit#heading=h.gjdgxs
  
−
* [[What Are Profiles?]]
 
−
** [[Media:COPD_Profile_v1.0.doc|COPD Profile v1.0]]
 
  
−
*[[Media:Mr ODonnell QIBA Process Roadmap 20090629.ppt.pdf|Thoughts on the QIBA Process: Profiles, UPICT & Measurements by Kevin O’Donnell-20090629]]
+
* [[Media:QIBA_CT_Lung_Density_Profile_090420-clean.pdf | QIBA CT Lung Density Profile_09.04.2020, clean version]] (Contains Conformance Checklist, Appendix B)
 +
* [[Media:QIBA_CT_Lung_Density_Profile_090420-marked.pdf | QIBA CT Lung Density Profile_09.04.2020, with markup]] (Contains Conformance Checklist, Appendix B)
 +
* [[Media:AAPM Comments QIBA CT Lung Densitometry final-SBF031620.pdf | AAPM Comments for CT Lung Density Profile]]
  
−
* [[Claim Language/Detail]]
+
* [[Media:QIBA_CT_Lung_Density_Profile_090319-clean.pdf | QIBA CT Lung Density Profile_09.03.2019]] (Contains Conformance Checklist, Appendix B)
 +
* [[Media:checklist.pdf | QIBA CT Lung Density Profile Checklist, 09.03.2019]] (separate Conformance Checklist for ease of reference)
 +
:*[[Media:QIBA CT Lung Density Protocols-Appendix E.xlsx|Appendix E:CT Lung Density Protocols 2019-06-26]]  
  
 +
* [[Media:QIBA_CT_Lung_Density_Profile_062619-appendix-resolved.pdf | QIBA CT Lung Density Profile_06.26.2019]] (Distributed August 21, 2019)
 +
* [[Media:QIBA_CT_Lung_Density_Profile_062619.docx | QIBA CT Lung Density Profile_06.26.2019]] (for BC and CC votes to release)
 +
* [[Media:QIBA_CT_Lung_Density_Profile_042519.docx | QIBA CT Lung Density Profile_04.25.2019]] (for internal BC review)
 +
* [[Media:QIBA_CT_Lung_Density_Protocols_Appendix_D_042519.xlsx | QIBA CT Lung Density Protocols, Appendix D_04.25.2019]] (for internal BC review)
 +
* [[Media:QIBA_CT_Lung_Density_Profile_022519.docx | QIBA CT Lung Density Profile_02.25.2019]] (for internal BC review)
  
−
===Groundwork Activities===
+
* [[Media:QIBA_CT_Lung_Density_Profile_083017-Clean.docx | QIBA CT Lung Density Profile_08.30.2017]] (for internal BC review)
−
Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.
+
* [[Media:QIBA_AirwayProfile.doc| QIBA Airway Profile 9/28/11 - (draft per Dr. Sean Fain)]]
 +
* [[Media:Profile_VerIowa_LungDensity_090611_BS.SF.doc|Lung Density QIBA Profile 9/6/11 v0.4 - (Iowa Version with comments)]]
  
−
* Phantom project
+
'''''[[Archive - Lung Density]]'''''
  
 +
==Protocol Development Activities==
  
−
==Meetings / Call Summaries==
+
*[http://upictwiki.ctsa-imaging.org/index.php?title=UPICT_Template UPICT Template]
  
−
*[[COPD Group Call Summaries]]
+
 
 +
==Groundwork Activities==
 +
Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.
 +
 
 +
* Phantom project
  
  
 
==Working Documents==
 
==Working Documents==
−
 
 
*[[Media:COPDDensityMatrix-V3.xls|COPD Density Matrix V3]]
 
*[[Media:COPDDensityMatrix-V3.xls|COPD Density Matrix V3]]
−
 
 
*[[Media:COPDMorphologyMatrix-V1.xls|COPD Morphology Matrix V1]]
 
*[[Media:COPDMorphologyMatrix-V1.xls|COPD Morphology Matrix V1]]
  
  
 
==Reference Documents==
 
==Reference Documents==
 +
* [[Media:Quantitative Imaging in Lung Disorders Refresher Course Outline.doc| Quantitative Imaging in Lung Disorders Refresher Course Outline (Refresher Course at RSNA 2011:  November 30th)]]
 +
*[[Media:06-21-2011GammexBoxFullPath.ppt|06-21-2011GammexBoxFullPath.ppt]] ''posted 6.23.2011''
 +
*[[Media:06-08-2011COPDGeneModel2-GammexBox.ppt|06-08-2011 COPDGeneModel2-GammexBox.ppt]] ''posted 6.8.2011''
 +
*[[Media:Madani - multi-slice cut off-20100421.pdf|Pulmonary Emphysema: Objective Quantification at Multi–Detector Row CT—Comparison with Macroscopic and Microscopic Morphometry]] Madani et al, Radiology: Volume 238: Number 3-March 2006
 +
*[[Media:Madani - Dose CT-3-20100421.pdf|Pulmonary Emphysema: Radiation Dose and Section Thickness at Multidetector CT Quantification—Comparison with Macroscopic and Microscopic Morphometry]] Madani et al, Radiology: Volume 243: Number 1-April 2007
  
 
*[[Media:Imaging_Section_of_MOP.doc|COPDGene protocol section]]
 
*[[Media:Imaging_Section_of_MOP.doc|COPDGene protocol section]]
Line 55: Line 91:
 
*[[Media:Stoel2008PATS-longitudinalstudies.pdf|Stoel et al's paper on longitudinal studies]]
 
*[[Media:Stoel2008PATS-longitudinalstudies.pdf|Stoel et al's paper on longitudinal studies]]
 
*[[Media:FDA-COPDGuidance-20100201.pdf|FDA Guidance for Industry - Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment]]
 
*[[Media:FDA-COPDGuidance-20100201.pdf|FDA Guidance for Industry - Chronic Obstructive Pulmonary Disease: Developing Drugs for Treatment]]
 +
 +
 +
==QIBA Funded Projects==
 +
 +
====Round 2====
 +
*[[University of Wisconsin]]
 +
 +
====Round 4====
 +
*[[Media:Low CT Dose Lung Protocols for Repeatable Quantitative Measures in Multi-Center Studies.pdf | Project (Y) Low CT Dose Lung Protocols for Repeatable Quantitative Measures in Multi-Center Studies (University of Wisconsin, Madison)]]
 +
 +
====Round 5====
 +
*[[Media:Investigation of Methods of Volume Correction for Lung Density CT.pdf | Project (L) Investigation of Methods of Volume Correction for Lung Density CT (University of Wisconsin, Madison)]]
 +
 +
====Round 6====
 +
*[[Media:Translating Phantom Harmonization to Clinical Practice.pdf | Project (U) CT Lung Density Biomarker-Translating Phantom Harmonization to Clinical Practice (National Jewish Health)]]

Latest revision as of 21:13, 21 September 2023

Co-chairs: Charles Hatt, PhD; Miranda Kirby, PhD
RSNA Staff Support: Julie Lisiecki

Scope

Scope: Quantitative CT lung densitometry and morphology for COPD and related diseases.

Initial Objectives:

  • Characterize the precision and accuracy of phenotyping and progression measurements in emphysema and asthma.
This is an essential effort to classify phenotype and assess longitudinal changes as medically meaningful surrogates for health status.
  • Compare the sensitivity of CT measurements to spirometry and other accepted measures.
This will be necessary in order to determine if Progressive Disease can be detected significantly sooner with quantitative imaging techniques than with currently accepted methods.

Recent Meetings/Call Summaries


Lung Density/COPD BC Call Summaries Archive

Profile Development

Status - <summarize current status>

A Google link for Public Comment Resolution has been created for ease of sharing updates with the group: https://docs.google.com/document/d/1uOzBaB_77vLSv8FKtQ59AxpfcAswtJ4t/edit#heading=h.gjdgxs


Archive - Lung Density

Protocol Development Activities


Groundwork Activities

Validate key concepts and answer key questions needed to write the Profiles and demonstrate their effectiveness.

  • Phantom project


Working Documents


Reference Documents


QIBA Funded Projects

Round 2

Round 4

Round 5

Round 6

Retrieved from "https://qibawiki.rsna.org/index.php?title=Lung_Density_Biomarker_Ctte&oldid=19254"